Women treated with @ and @ mg daily oxybutynin vaginal ring had significantly fewer incontinence episodes weekly ( p = @ and p = @ , respectively ) , lower daily urinary frequency ( p = @ , p = @ ) and a higher proportion had no incontinence episodes at week @ ( p = @ , p = @ ) compared with placebo .